At CiteAb, we collect highly structured data from the scientific literature which means we are able to segment reagent information by over 14 research areas. We used the following methodology to determine the award winner in this category:

• Calculating the supplier with the largest percentage increase in citations for a specific product in the cancer research area
• Limiting our analysis to bioactive data
• Excluding companies with under 10 citations

Congratulations to SelleckChem with their highly selective inhibitor of CDK4/6 - a protein-serine kinase which has a role in cell cycle regulation and is often deregulated in cancers.

Rebecca Sadler, Head of Product, commented:

"We present the CiteAb Awards at AACR each year and so we're always interested to look into relevant cancer research data at this time. For this category, we focused on bioactives given their key roles in studying cancer mechanisms. SelleckChem's S1116 - Palbociclib (PD-0332991) HCI increasing citation growth shows how it is helping researchers drive progress and findings in this important field.”

You can find out more about how the CiteAb database used in our Awards also powers our Reagent Search Engine, Data Licensing for researchers and Data Services for reagent suppliers on our website: www.citeab.com.